ACR 0.00% 6.3¢ acrux limited

Marketcap : 176 mio$Outlook:Licensing - secure significant new...

  1. 92 Posts.
    Marketcap : 176 mio$

    Outlook:

    Licensing - secure significant new deal

    Evamist™ - VIVUS files Evamist marketing application with FDA
    (achieved September 2006)

    Testosterone MDTS® - VIVUS starts Phase 3 trials (H1 2007)

    Contraceptive sprays - start proof of concept trials of combinations

    Testosterone MD-Lotion® - complete Phase 2 trials (H1 2007)

    New products - one successful proof of concept trial

    Fentanyl UDTS™ - open IND with FDA for Phase 2

    Cash - maintain above $10 million at all times
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
6.3¢
Change
0.000(0.00%)
Mkt cap ! $18.31M
Open High Low Value Volume
6.3¢ 6.3¢ 6.0¢ $9.464K 154.3K

Buyers (Bids)

No. Vol. Price($)
1 68974 6.3¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 4393 1
View Market Depth
Last trade - 14.31pm 16/08/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.